Cargando…
A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer
The management of stage II colorectal cancer is still difficult. We aimed to construct a new immune cell-associated signature for prognostic evaluation and guiding chemotherapy in stage II colorectal cancer. We used the “Cell Type Identification by Estimating Relative Subsets of RNA Transcripts” (CI...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585080/ https://www.ncbi.nlm.nih.gov/pubmed/32855365 http://dx.doi.org/10.18632/aging.103707 |